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Background
We recently discovered that soluble guanylyl cyclase
(sGC) activity is modulated by S-nitrosation, the addi-
tion of a NO moiety to the free thiol of cysteines (Cys).
Pathologically, we observed that exposure to low, thera-
peutic levels of nitroglycerin in rats led to decreased
vascular response to NO in the arterioles of hamster
cheek pouch, which correlated with S-nitrosation and
desensitization of sGC. As nitroglycerin-induced toler-
ance is a model of oxidative vascular dysfunction with
increase in superoxide generation, we hypothesized that
sGC activity could be affected in some types of oxidative
cardiovascular diseases (CVD) via oxidation of its thiols.
Methods
We used Angiotensin II (Ang II)-induced hypertension as
a model to assay whether decreased vascular reactivity to
NO, sGC S-nitrosation and desensitization take place and
contribute, in part, to this oxidative pathology. In addition,
we used Ang II treatment of A7r5 smooth muscle cells
(which do not have detectable sGC activity) infected with
adenoviruses expressing sGC and Cys mutants to explore
the potential molecular mechanisms of desensitization and
nitrosation of sGC by oxidative stress.
Results
Infusion of Ang II (0.7mg/kg/day) for 7days, in addition
to increasing mean arterial blood pressure and oxidative
stress, increases global S-nitrosation in rat thoracic aorta.
In vivo, resistance to relaxation induced by NO donors in
rat cremasteric arterioles was observed suggesting that
sGC sensitivity to NO is reduced in Ang II-treated ani-
mals. Conversely, biochemical analysis indicated that
NO-dependent cGMP production is decreased in tissues
of Ang II–treated rats, which is associated with S-nitrosa-
tion of sGC, while the expression levels of sGC were
similar in control and Ang II-treated rats. In vitro,w e
found that Ang II treatment (100nM, 4h) of A7r5 SMC
infected with sGC-expressing adenoviruses reduces NO-
stimulated activity by 50% and induces strong S-nitrosa-
tion of sGC. Mutational analysis of Cys, previously identi-
fied as S-nitrosated, indicated that aC516 mediates Ang
II-induced NO desensitization.
Conclusion
We showed that Ang II treatment, probably via induced-
oxidative stress, alters sGC sensitivity to NO by thiol oxi-
dation of its Cys, in particular C516. We propose that
this thiol-dependent desensitization of sGC to NO con-
stitutes a potential mechanism of decreased vascular
reactivity in Ang II-induced hypertension, in addition to
the well-documented decrease in NO bioavailability.
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